1.
Raybarman C, Bhattacharjee S. Aerosolized type II transmembrane serine protease 2 inhibitor to combat COVID-19: a proposal. Int J Contemp Pediatr [Internet]. 2021 Nov. 23 [cited 2026 Mar. 26];8(12):1996-7. Available from: https://www.ijpediatrics.com/index.php/ijcp/article/view/4584